Transcription directed by the human immunodeficiency virus type 2 long terminal repeat (HIV-2 LTRl responds to Tcell antigen receptor signaling. Agents that stimulate T-cell signaling pathways activated by the antigen receptor, such as phorbol ester, plant lectin, or anti-CD3 antibody treatment, have been shown to increase transcription directed by the HIV-2 LTR. In this study, we examine the activation of the HIV-2 LTR in T cells stimulated with the physiologic ligand of the T-cell receptor, antigenic peptide presented by a major histocompatibility molecule. HIV-2 reporter plasmids were transfected into the antigen-specific T-cell hybridoma, 2B4.11, where they responded to antigen-dependent NE OF THE PRIMARY CELLS infected by the human immunodeficiency viruses type 1 and type 2 (HIV-1 and HIV-2) is the CD4' T lymphocyte. Viral replication in these cells is regulated at the transcriptional level, and can be induced by T-cell activation."' The retroviral long terminal repeats (LTR) of HIV-1 and HIV-2 contain the cis-acting DNA sequences that direct messenger RNA synthesis by cellular factors in T lymphocytes. HIV-2 transcriptional regulation by cellular factors in T cells is distinguished from HIV-1 transcriptional regulation because HIV-2 is more inducible by agents that mimic T-cell antigen receptor signaling." The transcriptional control elements contained in the HIV-2 LTR include a single functional KB element, in contrast to the tandem pair in HIV-l.'o*ll Other HIV-2 regulatory elements, which are not present in HIV-l, help mediate transcriptional induction in Jurkat T cells stimulated with phorbo1 myristyl acetate (PMA), phytohemagglutinin (PHA), or soluble anti-CD3 monoclonal antibodies (MoAbs) (0KT3).'0,12 The responsiveness of the HIV-2 LTR to T-cell receptor-CD3 (TCR-CD3) stimulation by anti-CD3 antibodies led us to examine HIV-2 regulation during T-cell activation by more physiologic means.
physiologic ligand of the TCR to activate pathways leading to changes in T-cell gene expression. The necessary ligand in the present study is a cytochrome c antigenic peptide presented by I-E' MHC molecules on the surface of the antigen presenting cell LK35.2.18 The 2B4.11 hybridoma line, and its parental clone 2B4, have been used to study the signal transduction processes associated with antigen presentation." In this cell line, stimulation of the antigen receptor leads to the activation of intracellular signaling pathways ultimately leading to the production of lymphokines such as interleukin-2 (IL-2). Changes in protein tyrosine phosphorylation are detected first, followed by phosphatidylinositide hydrolysis, an increase in cytoplasmic calcium concentration, and changes in serine phosphory1ation.l' These physiologic changes have been described in 2B4.11 cells as well as in mature primary T ~e l l s .~~-~~ Through such signal transduction pathways, antigen/MHC recognition by the T cell may modulate a distinct set of transcriptional regulatory proteins resulting in coordinate alterations of gene e x p r e~s i o n .~~.~~ Induction of HIV-2 transcription may proceed through a mechanism that uses the same regulatory proteins in activated T cells that increase IL-2 transcription. Their enhancers include elements that bind similar Ets family members (purine boxes) and NF-KB-like proteins (KB site^).'*.^^-^^ We have used the 2B4.11 cells in the following transient transfection studies to take advantage of their antigen specificity and well-known biochemical response to stimulation (ie, IL-2 secretion). In this study, we show that such signals in the 2B4.11 cells are able to activate the HIV-2 LTR. Transcription is induced in response to mitogen, anti-CD3 antibody and MHC-restricted antigen treatment. We also show that at least four regulatory elements in the HIV-2 LTR are required for the optimal response to these stimuli in the 2B4.11 cells.
MATERIALS AND METHODS

Cells and growth conditions.
The human T-leukemia cell line Jurkat was maintained in RPM1 with 5% fetal bovine serum (FBS), 50 UlmL penicillin, 50 pglmL streptomycin, and 2 mmol/L glutamine under standard culture conditions. 2B4.11. an I-Ek restricted 
6.1
Stimulant:
----pl-a cm "-PMA CD3 PMA murine T-cell hybridoma bearing antigen receptors specific for cytooma," were generously provided by Stuart Frank (National Institutes of Health, Bethesda, MD). The 2B4.11 cell line is a subclone of the 2B4 hybridoma line (clone A-li7) derived from T cells reacting to pigeon cytochrome c. The 2B4.11 antigen receptor recognizes epitopes in the carboxy terminal cyanogen bromide fragment of the cytochrome c protein (amino acid residues 81 through 104). LK35.2 cells bear I-E' MHC class I1 molecules and F, receptors and will present peptide antigen and cross-link antibodies. LK35.2 and 2B4.11 cells were grown under the same conditions as for Jurkat cells, except the medium was supplemented with 50 pmovL 2-mercaptoethanol, and 284.11 cells were grown in medium with 10% FBS.
Antibodies. 2C11 MoAb, specific for murine CD3E, was used as a tissue culture supernatant from the hamster-mouse somatic Bcell hybridoma 145-2C1 l,33 provided by S. Shu (University of Michigan, Ann Arbor, MI) with the permission of J. Bluestone (University of Chicago, Chicago, IL). BB7.1 MoAb, specific for human HLA-B7, was used as a tissue-culture supernatant from the BB7.1 hybridoma obtained from the American Type Culture Collection (Rockville, MD). OKT3 MoAb specific for human CD3 was prepared as ascites fluid and provided by D. Fox (University of Michigan). Rabbit IgG fraction to hamster IgG (whole molecule) was purchased from Cappel (Durham, NC) and reconstituted following directions provided with the product. Goat affinity purified antibody to mouse IgA + IgG + IgM (heavy and light chains) was purchased from Kirkegaard & Perry Laboratories Inc (Gaithersburg, MD) and reconstituted according to procedure B provided with the product.
Antigen. Pigeon breast muscle cytochrome c was purchased from Sigma (St Louis, MO) and subjected to cyanogen bromide (CNBr) cleavage as previously de~cribed.'~ One hundred milligrams of cytochrome c was cleaved with 25 mg CNBr overnight at room temperature in 10 mL of 70% formic acid. H20 was then added to 100 mL and this solution was either evaporated in a rotary evaporator or lyophilized to dryness. The pellet was resuspended in 3 mL of 7% formic acid and applied to a 115 cm X 2.5 cm Sephadex G25 column (Pharmacia, Piscataway, NJ) equilibrated with a 7% formic acid solution. Three absorption peaks at 280 nm were detected in 120 5-mL fractions. To determine which fractions contained the antigenic peptide (residues 81 through 104), samples from the peak fractions were subjected to mass analysis by electrospray mass spectrometry on a single quadruple mass spectrometer. The fractions containing the antigenic peptide, along with fractions containing a nonantigenic peptide (residues 66 through SO), were separately pooled and lyophilized. Peptides were quantitated using the molar extinction coefficient for each peptide as determined by the Peptide- . Before use, the peptides were resuspended in phosphate-buffered saline (PBS) and diluted into medium with serum.
Plasmids. HIV-2-chloramphenicol acetyltransferase (HIV-2-CAT) native and substitution mutants have been described else-HIV-2RoD strain (556/+156). 35 Plasmids were double banded in cesium chloride equilibrium gradient centrifugations.
Transfection. A modified diethyl aminoethyl (DEAE)-dextran method was used for both Jurkat and 2B4 cells. Cells (1 X 10') were spun at 1, OOO rpm (230g) for 5 minutes. Cells were washed once with 10 mL STBS (25 mmol/L TRIS-HCI pH 7.4, 137 mmoV L NaCI, 5 mmol/L KCl, 0.6 mmoVL NaZHPO4, 0.7 mmol/L CaCI2, 0.5 mmoVL MgClZ) and then resuspended in 1.0 mL of an STBS solution containing 10 pg of reporter plasmid and 500 pg/mL DEAEdextran. Incubation of the cells with DNA for 30 minutes at 37°C was followed by chloroquine treatment for 30 minutes at 37°C using 10 mL of RPMI + 5% FBS, penicillin, streptomycin, glutamine, and 100 pmoVL chloroquine. The cells were spun again, washed with 10 mL of RPMI, and finally resuspended in 20 to 30 mL of RPMI of 5% FBS, penicillin, streptomycin, and glutamine.
Stimulation of T cells. Five milliliters of cells was treated at
approximately 24 hours after transfection with either mitogens, antibodies, or peptides. Each transfection was split into several wells that received no stimulation or the following treatments:
Mitogen treafment. Jurkat and 2B4.11 transfectants were treated with PMA (Sigma) at 10 ng/mL and PHA (Sigma) at 2 pgImL. (Fig  2) . Because the HIV-2-CAT reporter responded to TCR-CD3 complex stimulation to a similar extent, further study of the HIV-2 enhancer was pursued using the 2B4.11 cells.
Addition (Fig 3) . Soluble 2C11 treatment is weakly stimulatory, but once bound to either the surface of the tissue-culture well or the Fc receptor on the surface of the LK35.2 cells, this antibody can stimulate HIV-2 transcription approximately 25-fold (Fig  3) . Treatment with a control MoAb, BB7.1, recognizing the human HLA-B7 molecule, did not greatly stimulate HIV-2-CAT in the absence or presence of irradiated LK35.2 cells or when bound to the tissueculture well (Fig 3) . Similar results were seen when the 2C11 and BB7.1 antibodies were immobilized on antimurine Igcoated tissue-culture wells (data not shown).
Physiologic activation of 2B4. I I cells by antigen activates
HIV-2 LTR. Regulation of HIV-2 in 2B4.11 cells was also examined by MHC-restricted antigen presentation. The pigeon cytochrome c peptide antigen (amino acid residues 81 through 104) was able to activate HIV-2 only when irradiated LK35.2 cells were present (Fig 4A) . Incubation with a nonantigenic cytochrome c peptide (residues 66 through 801, did not increase HIV-2 transcription (Fig 4B) . These results suggest that stimuli acting through the TCR-CD3 complex, particularly antigen presentation. increase HIV-2 transcription in a manner similar to mitogen treatment.
HIV-2 transcriptional regulatory elements participate in 2B4. l l cell activation mediated by antigen presentation as well as mitogen and anti-CD3 antibody treatment. Knowing that mitogen, anti-CD3 antibody, and antigen stimulation of 2B4.11 cells will activate the native HIV-2 LTR, experiments were performed to delineate the role of individual HIV-2 enhancer elements by transfecting HIV-2-CAT plasmids bearing site-directed substitution mutations. The 2B4.11 transfectants were then cocultured with irradiated ... Four single-site mutants and two double-site mutants were examined (see Fig 1) . APuBl contains substitutions in the purine box PuBl (CD3R) element, originally characterized as being CD3 responsive, that is, conferring inducibility of HIV-2 to anti-CD3 antibody treatment of Jurkat cells." Apets contains a 6-bp substitution in an element, recognized by a nuclear protein, that contributes to the PMA responsiveness of the HIV-2 LTR." APuB2 substitutes bases in another purine box adjacent to the pets site." AKB substitutes bases in the single functional KB element in the HIV-2 enhancer." Each of these single-site mutants causes a diminished basal enhancer activity and inducibility of the HIV-2 LTR by mitogens, anti-CD3, or antigen (Fig 5) . Both the AKB and the APuB2 mutant plasmids reduce the inducibility of the HIV-2 LTR to a large extent. This suggests that the purine box element plays just as important role in the HIV-2 enhancer as the KB element. The two double-site mutants, APuBl + APuB2 and APuBl + AKB, contain substitutions in the two purine boxes or the PuBl plus KB element, respectively.'2341 Both of the double mutants exhibited a small degree of inducibility in response to mitogen, anti-CD3 antibody, or antigen treatment. This suggests that even with two of the four identified enhancer elements mutated, the remaining cis-acting regulatory sites can mediate some increase in transcription during 2B4.11 activation.
DISCUSSION
Previous studies of HIV-2 transcriptional regulation in T cells have utilized transient transfection of HIV-2 LTR reporter plasmids into transformed human T-cell lines.''-12~36. 37 These analyses have allowed the role of cellular factors involved in activating the HIV-2 LTR to be examined when the transfected T cell lines are activated by mitogen and antibody treatment. This work extends the study of HIV-2 transcriptional regulation to the physiologic T-cell activation process encountered in vivo, MHC-restricted antigen presentation. The murine T-cell hybridoma 2B4.11 has been extensively studied as a model for antigen receptor-mediated activation, and we have developed a transient transfection assay using these cells to investigate transcriptional activation. Antigen presentation of 2B4.11 cells induces the HIV-2 LTR to similar levels as mitogen or anti-CD3 treatment. The identified HIV-2 transcriptional control elements, PuB1, pets, PuB2, and a KB site, play a role in basal HIV-2 transcription as well as inducible transcription after treatment with any of the stimulatory agents. Each single mutant plasmid also responds similarly to the three treatments used to activate the cell, suggesting that activation pathways triggered by the treatments act to an equivalent degree upon each element.
Ideally, the study of HIV-1 and HIV-2 transcriptional regulatory elements would be performed in primary CD4' T cells, but these cells are refractory to many DNA transfection techniques. In addition, successful transfection of HIV-1 reporter plasmids into primary T cells requires preactivation, confounding studies of T-cell activation. In the cases in which the HW-1 enhancer activity has been analyzed in this way,14315 similar results are observed to our studies with HIV-1 reporter plasmids in 2B4.11 cells.M Because of the similarities with HIV-1 in primary T lymphocytes and 2B4.11 cells, the transfection system in this report is physiologically relevant and offers a model to analyze the biochemical basis of antigen-mediated stimulation of HIV transcription. Whereas the 2B4.11 hybridoma generates similar signals and increases in IL-2 transcription like primary T cells, it undergoes apoptosis after antigen activation. Most primary mature T cells will proliferate in response to antigen, but under certain conditions, primary T cells also undergo apoptosis after antigen-receptor s t i m u l a t i~n .~~~~~ Given that the early signaling pathways and the IL-2 and HIV-1 transcriptional responses are similar in 2B4.11 and primary T cells, HIV-2 transcription may be expected to be regulated similarly. However, we cannot rule out that apoptotic versus proliferative pathways may differentially regulate the specific elements in the HIV-2 enhancer.
Besides having the conserved KB element in the retroviral LTR, the various HIV-2 isolates conserve the three upstream regulatory elements examined in this and previous report~.",'~ The PuB1, pets, and PuB2 sites, each of which help mediate transcriptional activation in T cells, are highly conserved across most HIV-2 isolates (Fig 6) . The conservation of PuBl and PuB2 extends to the simian immunodeficiency viruses (SIVs) isolated from macaques. The PuB2 element is also conserved in the more distantly related mandrill (SIVMNDGBl) and African green monkey (SIVAGM) isolates. Functional analysis of transcription directed by an SIVMAc LTR of the SIVMM142 isolate suggests the importance of these elements. Study of this SIV LTR in Rat-l fibroblasts and Jurkat T cells has shown a 48-bp sequence 5' to the single KB site that behaves as an enhancer involved in basal transcription as well as PMA inducibility.40 This region, from -162 to -1 14 relative to the transcription initiation site, contains the conserved SIV LTR sequences related to the HIV-2 PuBl and PuB2 elements, supporting the important regulatory role of these sites.
The two purine box elements of the HIV-2 LTR have been shown to be recognized by Elf-l, a protein expressed in T cells that is a member of the Ets family.'2.27.4' In several other promoters and enhancers, such purine box cis-acting sequences have been shown to be recognized by Ets family members as we11.27,42-45 Some of these sites are closely associated with other DNA regulatory elements, most notably the polyomavirus enhancer A binding protein (PEA1) site, which is essentially an AP-1 binding site."6 Sequences related to the polyomavirus purine box have also been described in the c-fos promoter adjacent to or part of the serum response and the urokinase enhancer adjacent to an activation transcription factor/cyclic adenosine monophosphate (AMP) response element (ATF/CRE).48 The Elf-l purine box binding site in the NF-AT enhancer element of the IL-2 gene is adjacent to binding sites for Fos and
The NF-AT site was initially described as an antigen-receptor response element.'o*" Finally, several other regulatory sequences have been shown to contain purine box elements adjacent to other AP-1 or ATF/CRE-like sites (Fig 7) .
The findings in this report suggest that transcriptional regulatory sequences in the HIV-2 LTR, which are conserved across primate immunodeficiency virus groups, contribute to the antigen-MHC mediated induction of HIV-2 gene expression in T cells. Further studies will be needed to address the functional role of Ets family members binding to the h B l and PuB2 elements, the NF-KB/rel proteins binding to the KB element, and the nature of the proteins recognizing the pets element. Determining what modification occurs to these proteins to increase viral transcription also needs to be examined because PUB 1, PuB2, and pets are bound constitutively by nuclear
The position of the PuBl, h B 2 , and pets element parallels that of the NF-AT site in the IL-2 enhancer, although there is no evidence to suggest that NF-AT binds to the HIV-2 enhancer. Additionally, the contribution of other functional regulatory elements also needs to be considered, such as the SP1 sites 3' of the HIV-2 KB element or other unidentified sites. The other unexamined elements may provide binding sites for proteins that allow efficient HIV-2 transcription during cellular activation. Thus, although HIV-2 and E -2 both display increased transcription after T-cell antigen-receptor stimulation, these genes use distinct combinations of transcription factors to mediate this effect. Therefore, the HIV-2 enhancer provides an independent model to analyze antigen-mediated T-cell transcriptional activation. Because the signal transduction pathways have been well characterized in these cells, such studies will not only provide insight into HIV-2 regulation, but also help to define the sets of transcription factors by which disparate genes respond to T-cell activation.
